Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya to treat uUTIs.

Allecra Therapeutics, founded in 2013, is a private, clinical-stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms.

CHENNAI, (IANS) – Vertically integrated pharma player Orchid Pharma Ltd said on February 23 that it will launch its Enmetazobactam drug in the US in the next couple of quarters.

GUWAHATI: A molecule, Enmetazobactam, for which a team of scientists, including Assam's Dr. Mukut Gohain, received a US patent as one of the inventors in 2008, has now received the green light to ...

Allecra – which licenses enmetazobactam from Indian drugmaker Orchid Pharma ... the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.

Allecra Therapeutics (Allecra) and Acino announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra’s antibiotic drug Exblifep ...

New Delhi, Orchid Pharma Ltd on Friday said it has partnered with Cipla for the launch and distribution of its new antibiotic Cefepime-Enmetazobactam in India.The company's new drug - Cefepime ...

Chennai, Feb 23 (IANS) Vertically integrated pharma player Orchid Pharma Ltd said on Friday that it will launch its Enmetazobactam drug in the US in the next couple of quarters.